高エネルギー医学研究部門

氏名所属

職名

取得学位

専門分野

主な論文・著作・業績①Kimura K, Kubo Y, Dobashi K, Katakura Y, Chida K, Kobayashi M, Yoshida K, Fujiwara S, Terasaki K, Kawamura
T, Ogasawara K. Angiographic, Cerebral hemodynamic, and cognitive outcomes of indirect revascularization
surgery alone for adult patients with misery perfusion due to ischemic moyamoya disease. Neurosurgery.
90(6):676-683(2022)②Igarashi S, Ando T, Takahashi T, Yoshida J, Kobayashi M, Yoshida K, Terasaki K, Fujiwara S, Kubo Y, Ogasawara
K. Development of cerebral microbleeds in patients with cerebral hyperperfusion following carotid endarterectomy
and its relation to postoperative cognitive decline. J Neurosurg. 1:1-7(2021)

寺崎一典

高エネルギー医学研究部門

核薬学准教授博士(医学)

放射線薬品学
分子イメージング③Iwata R, Terasaki K, Ishikawa Y, Harada R, Furumoto S, Yanai K, Pascali C. A concentration-based microscale
method for 18F-nucleophilic substitutions and its testing on the one-pot radiosynthesis of [18F]FET and[18F]fallypride. Appl Radiat Isot. 166:109361(2020)④Takahashi T, Kobayashi M, Fujiwara S, Kubo Y, Terasaki K, Ogasawara K. Decrease in 18F-Florbetapir
accumulation in the cerebral hemisphere with hypoperfusion and misery perfusion due to chronic atherosclerotic
occlusion of the internal carotid artery. Clin Nucl Med. 45(2):e115-e116(2020)⑤Oikawa K, Kobayashi M, Beppu T, Terasaki K, Ogasawara K. Resolution of hypoxic tissue in cerebellar
hemispheres after arterial bypass surgery in a patient with symptomatic bilateral vertebral artery occlusion: a 18FFRP170 PET study. Clin Nucl Med. 44(4):295-296(2019)⑥Roppongi M, Izumisawa M, Terasaki K, Muraki Y, Shozushima M. 18F-FDG and 11C-choline uptake inproliferating tumor cells is dependent on the cell cycle in vitro. Ann Nucl Med. 33(4):237-243(2019)①Beppu T, Iwaya T, Sato S, Nomura J, Terasaki K, Sasaki T, Yamada N, Fujiwara S, Sugai T, Ogasawara K. : PETwith 11C-methyl-L-methionine as a predictor of consequential outcomes at the time of discontinuing
temozolomide-adjuvant chemotherapy in patients with residual IDH-mutant lower-grade glioma/Clin Nucl Med.
47(7):569-574(2022)②Beppu T, Sato Y, Yamada N, Terasaki K, Sasaki T, Sugai T, Ogasawara K. : Impacts on histological features and11C-methyl-L-methionine uptake after one-shot administration with bevacizumab before surgery in newly
diagnosed glioblastoma/Transl Oncol. 12(11): 1480-1487(2019)

佐々木敏秋

高エネルギー医学研究部門

講師

博士(工学)

放射線科学③Beppu T, Sasaki T, Sato Y, Terasaki T. : High-uptake areas on 18F-FRP170 PET image necessarily include

核医学

proliferating areas in glioblastoma : a superimposed image study combining 18F-FRP170 PET with 11Cmethionine PET/Advances in Molecular Imaging. 7:1-11(2017）④Beppu T, Terasaki K, Sasaki T, Sato Y, Tomabechi M, Kato K, Sasaki M, Ogasawara K. : MRI and 11C-methyl-Lmethionine PET differentiate bevacizumab true responders after initiating therapy for recurrent glioblastoma/Clin
Nucl Med. 41(11):852-857 (2016)⑤Beppu T, Sasaki T, Terasaki K, Saura H, Mtsuura H, Ogasawara K, Sasaki M, Iwata R, Takai Y. : High-uptake
areas on positron emission tomography with the hypoxic radiotracer 18F-FRP170 in glioblastomas include regions
retaining proliferative activity under hypoxia/Ann Nucl Med. 29:336-341(2015)